Severe eosinophilic asthma can now be treated with biologic therapies that reduce attacks and, in some cases, allow corticosteroid dose reductions. However, not all patients respond to these treatments, and it remains difficult to predict in advance who will benefit from them. A study conducted by scientists at the University of Liège and Liège University Hospital proposes using a "simple" breath sample to guide treatment selection even before it begins. The findings are published in the American Journal of Respiratory and Critical Care Medicine.
❓ Unknown
Breath Analysis May Predict Biologic Therapy Responses for Severe Asthma
1w ago
September 9, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A study from the University of Liège suggests that breath analysis can predict responses to biologic therapies for severe eosinophilic asthma, potentially improving treatment selection. This research may influence healthcare approaches in Iran, where asthma is a significant health issue. Understanding treatment responses could enhance patient care in Iranian hospitals.
🔍 Quick Context Guide
💡 Bottom Line:
Breath analysis could revolutionize asthma treatment by enabling tailored therapies, significantly impacting patient care.
👥 Key Players
University of Liège
MENTIONED
Research institution
"They are at the forefront of medical research, potentially influencing treatment protocols for asthma in various countries, including Iran."
Liège University Hospital
MENTIONED
Healthcare provider
"As a clinical partner in the study, their findings could directly impact patient care and treatment strategies."
📰 What Happened
Researchers at the University of Liège have discovered that breath analysis can predict how patients with severe eosinophilic asthma will respond to biologic therapies. This could lead to more personalized and effective treatment plans.
- The study suggests a non-invasive method for predicting treatment responses.
- Biologic therapies are crucial for managing severe asthma but are not universally effective.
💡 Why It Matters
🇮🇷 For Iran: Asthma is a prevalent health issue in Iran, and improved treatment selection could enhance patient outcomes and reduce healthcare costs.
🌍 Regional: If successful, this method could be adopted by healthcare systems across the Middle East, improving asthma management regionally.
🌐 International: This research could influence global asthma treatment protocols and encourage further investment in personalized medicine.
📚 Background
Severe eosinophilic asthma is a challenging condition that affects many patients worldwide, including in Iran. Current treatments are not effective for everyone, making predictive methods essential.
Asthma management
Biologic therapies
📡 Source:
NEUTRAL
📊 Confidence:
70%
The findings are published in a reputable medical journal, indicating a level of credibility in the research.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Pezeshkian Celebrates 200 Nights of Rallies, Affirms Support for Armed Forces
Just now •
Iran's President Pezeshkian Advocates for Diplomatic Resolution of Issues with Neighbors
12 min ago •
Iran War Financial Burden on the U.S. Exceeds $38 Billion
12 min ago •
Machine Learning System Enhances Cancer Cell Detection Through Light Scattering Analysis
12 min ago •